The estimated Net Worth of Eric Sjogren is at least $449 millier dollars as of 24 June 2019. Eric Sjogren owns over 21,739 units of Calithera Biosciences Inc stock worth over $3,603 and over the last 10 years he sold CALA stock worth over $0. In addition, he makes $445,144 as Senior Vice President - Drug Discovery at Calithera Biosciences Inc.
Eric has made over 2 trades of the Calithera Biosciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 21,739 units of CALA stock worth $20,869 on 24 June 2019.
The largest trade he's ever made was exercising 21,739 units of Calithera Biosciences Inc stock on 24 June 2019 worth over $20,869. On average, Eric trades about 2,409 units every 28 days since 2015. As of 24 June 2019 he still owns at least 72,057 units of Calithera Biosciences Inc stock.
You can see the complete history of Eric Sjogren stock trades at the bottom of the page.
Dr. Eric B. Sjogren Ph.D. serves as Senior Vice President - Drug Discovery of the Company. Dr. Sjogren joined Calithera in June 2010 and currently serves as our Senior Vice President of Drug Discovery. From 2003 to 2009, Dr. Sjogren was Vice President and Head of Medicinal Chemistry at Roche Palo Alto, LLC, where he directed a small molecule drug discovery team in the areas of inflammation, virology and central nervous system disorders. Dr. Sjogren received a B.A. in Chemistry from the University of California, San Diego and a Ph.D. in Chemistry from Harvard University.
As the Senior Vice President - Drug Discovery of Calithera Biosciences Inc, the total compensation of Eric Sjogren at Calithera Biosciences Inc is $445,144. There are 6 executives at Calithera Biosciences Inc getting paid more, with Susan Molineaux having the highest compensation of $2,209,840.
Eric Sjogren is 63, he's been the Senior Vice President - Drug Discovery of Calithera Biosciences Inc since 2010. There are 6 older and 16 younger executives at Calithera Biosciences Inc. The oldest executive at Calithera Biosciences Inc is H. Ward Wolff, 71, who is the Independent Director.
Eric's mailing address filed with the SEC is C/O CALITHERA BIOSCIENCES, INC., 343 OYSTER POINT BLVD. #200, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 10 years, insiders at Calithera Biosciences Inc have traded over $23,150,153 worth of Calithera Biosciences Inc stock and bought 7,859,025 units worth $49,155,939 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Capital Partners Gp, L.L.C.... et Deepika Pakianathan. On average, Calithera Biosciences Inc executives and independent directors trade stock every 43 days with the average trade being worth of $8,053. The most recent stock trade was executed by Deepika Pakianathan on 27 January 2023, trading 121,333 units of CALA stock currently worth $47,320.
calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells. calithera’s discovery and development efforts are focused on solid tumors for which new treatments are urgently needed. we are currently developing our lead candidate in phase 2 trials in patients with renal cell carcinoma, triple negative breast cancer. targeting cancer, differently. our onco-metabolism approach brings an enhanced perspective to cancer.
Calithera Biosciences Inc executives and other stock owners filed with the SEC include: